KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Sales (2016 - 2025)

Historic Return on Sales for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to 0.22%.

  • Emergent BioSolutions' Return on Sales fell 1700.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year increase of 3200.0%. This contributed to the annual value of 0.18% for FY2024, which is 5400.0% up from last year.
  • According to the latest figures from Q3 2025, Emergent BioSolutions' Return on Sales is 0.22%, which was down 1700.0% from 0.09% recorded in Q2 2025.
  • Over the past 5 years, Emergent BioSolutions' Return on Sales peaked at 0.39% during Q3 2024, and registered a low of 5.66% during Q2 2024.
  • Moreover, its 5-year median value for Return on Sales was 0.11% (2021), whereas its average is 0.45%.
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by -48900bps in 2024, then skyrocketed by 55800bps in 2025.
  • Emergent BioSolutions' Return on Sales (Quarter) stood at 0.24% in 2021, then crashed by -184bps to 0.2% in 2022, then grew by 12bps to 0.18% in 2023, then grew by 10bps to 0.16% in 2024, then soared by 238bps to 0.22% in 2025.
  • Its Return on Sales stands at 0.22% for Q3 2025, versus 0.09% for Q2 2025 and 0.31% for Q1 2025.